Skip to Main Content

Paper Details

Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies.
Blood
25
2022
Author NameAffiliation
Ralf HerwigMax-Planck-Institute for Molecular Genetics
Michal R SchweigerInstitute for Translational Epigenetics, University of Cologne
Michal R SchweigerCologne Center for Genomics (CCG), University of Cologne
Michal R SchweigerCenter for Molecular Medicine Cologne (CMMC), University of Cologne
  • 1 - 4

Datasets

Release 1.2